Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An inverse relationship between
protein kinase C
(
PKC
) activity and oestrogen receptor (ER) expression in human breast cell lines and tumours has been firmly established over the past 10 years. To determine whether specific alterations in
PKC
expression accompany hormone-independence, we examined the expression of
PKC
isozymes in the hormone-independent human breast cancer cell clones MCF-7 5C and T47D:
C42
compared with their hormone-dependent counterparts, MCF-7 A4, MCF-7 WS8 and T47D:A18 respectively. Both hormone-independent cell clones exhibit elevated
PKC
alpha expression and increased basal AP-1 activity compared with the hormone-dependent cell clones. To determine whether
PKC
alpha overexpression is sufficient to mediate the hormone-independent phenotype, we stably transfected an expression plasmid containing
PKC
alpha cDNA to the T47D:A18 and MCF-7 A4 cell lines. This is the first report of
PKC
alpha transfection in T47D cells. In contrast to MCF-7 cells, T47D has the propensity to lose the ER and more readily forms tamoxifen-stimulated tumours in athymic mice. We find that in T47D:A18/
PKC
alpha clones, there is concomitant up-regulation of
PKC
beta I and delta, whereas in the MCF-7 A4/
PKC
alpha transfectants
PKC
epsilon is up-regulated. In T47D:A18, but not in MCF-7 A4,
PKC
alpha stable transfection is accompanied by down-regulation of ER function whilst basal AP-1 activity is elevated. Our results suggest
PKC
alpha overexpression may play a role in growth signalling during the shift from hormone dependent to hormone-independent breast cancers.
...
PMID:Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines. 2765 37
The P2X(7) receptor (P2X7R) is a ligand-gated ATP receptor that acts as a low- and large-conductance channel (pore) and is known to be coupled to several downstream effectors. Recently, we demonstrated that the formation of a large-conductance channel associated with the P2X(7) receptor is induced by increasing the intracellular Ca(2+) concentration (Faria et al., Am J Physiol Cell Physiol 297:C28-
C42
, 2005). Here, we investigated the intracellular signaling pathways associated with P2X(7) large-conductance channel formation using the patch clamp technique in conjunction with fluorescent imaging and flow cytometry assays in 2BH4 cells and peritoneal macrophages. Different antagonists were applied to investigate the following pathways: Ca(2+)-calmodulin, phospholipase A, phospholipase D, phospholipase C,
protein kinase C
(
PKC
), mitogen-activated protein kinase (MAPK), MAPK/extracellular signal-regulated kinase, phosphoinositide 3-kinase (PI3K), and cytoskeletal proteins. Macroscopic ionic currents induced by 1 mM ATP were reduced by 85% in the presence of
PKC
antagonists. The addition of antagonists for MAPK, PI3K, and the cytoskeleton (actin, intermediary filament, and microtubule) blocked 92%, 83%, and 95% of the ionic currents induced by 1 mM ATP, respectively. Our results show that
PKC
, MAPK, PI3K, and cytoskeletal components are involved in P2X(7) receptor large-channel formation in 2BH4 cells and peritoneal macrophages.
...
PMID:Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells. 2050 16